Sclerosing agent

Known as: [CV600] SCLEROSING AGENTS, Sclerosing Agents, agent sclerosing 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1945-2018
0102019452017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
OBJECTIVE To determine which covariates predisposed to deep venous occlusion (DVO) after ultrasound-guided sclerotherapy (UGS… (More)
Is this relevant?
2007
2007
OBJECTIVE To estimate medium-term success after a technique for ultrasound-guided sclerotherapy for superficial chronic venous… (More)
Is this relevant?
2006
2006
OBJECTIVE To assess the efficacy and safety of sclerotherapy performed with polidocanol foam compared to liquid polidocanol… (More)
Is this relevant?
2006
2006
AIM Treatment of venous insufficiency has been revolutionized by introduction of less invasive endovenous procedures. Foam… (More)
Is this relevant?
2005
2005
Venous angiomata, or venous malformations, are often present at birth, although they may not be evident until later. They consist… (More)
Is this relevant?
2001
2001
BACKGROUND The aim of this work was to study the outcomes of echosclerosis using sclerosants in microfoam incompetent long… (More)
Is this relevant?
1995
1995
Intralesional bleomycin injection was used as sclerosant therapy for sixteen patients with cystic hygroma. An excellent (complete… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
A total of 207 patients with hemangiomas, vascular malformations, and lymphovenous malformations were treated by the same surgeon… (More)
Is this relevant?
1993
1993
Parathyroid cysts are uncommon: about 200 cases have been reported. They can be functional (i.e., accompanied by signs of primary… (More)
Is this relevant?
1989
1989
In 27 patients who had bled from esophagogastric varices, large-sized and/or actively bleeding gastric varices were… (More)
Is this relevant?